Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Sleep | Psychiatry/Psychology | Neurology | Family Medicine
Disease Category: Sleep Disorders
Location: United States, NY
Clinical trial to test a study drug in Patients with Chronic Hepatitis C
The purpose of this study is to evaluate the safety and
effectiveness of an FDA-approved study drug as a sleep aid as
compared to placebo (an inactive substance) in the treatment of
insomnia associated with interferon-induced insomnia in patients
with chronic hepatitis C (CHC). In addition, another purpose of
this study is to evaluate whether successful treatment of insomnia
decreases the likelihood of developing depression which can occur
during interferon treatment.
Study drug and study procedures will be made available to you at
To qualify, you must:
You will not qualify if you:
Research being conducted by:
CW ID: 118127
Date Last Changed:
July 25, 2013
Gregory Asnis, MDBiomedical Research Alliance of New YorkMontefiore Medical Center
Anxiety and Depression Clinic
111 East 210th StreetBronx, NY 10467Phone: 718-920-4287
Biomedical Research Alliance of New York
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2017 CenterWatch.